Rockwell, B., Mantzaris, I., Shastri, A., Jonas, B. A., Saunthararajah, Y., Levitz, D., Verceles, J., Cooper, D., Munoz, A., Dhawan, A., Pradhan, K., Kornblum, N., Sica, A. R., Peeke, S., Gupta, R., Gritsman, K., Konopleva, M., Feldman, E. J., Verma, A., Goldfinger, M. (2025). Dosing decitabine and venetoclax for terminal differentiation to improve outcomes in TP53 mutant MDS and AML.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.6514